{"id":"W2049880080","doi":"10.1158/1535-7163.targ-13-b81","title":"Abstract B81: Phase I/II trial of vorinostat in combination with etoposide in pediatric patients with relapsed/refractory solid tumors.","year":2013,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Vorinostat; Etoposide; Pharmacology; Internal medicine; Oncology; Regimen; Toxicity; Chemotherapy; Histone deacetylase; Biology; Histone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006771152,0.001069297,0.001160468,0.0002989122,0.0003374506,0.0005976075,0.0005154627,0.0007025844,0.003006794],"category_scores_gemma":[0.0003626838,0.0003806157,0.0004834305,0.0003885453,0.0004955858,0.0004884159,0.0002734293,0.002090093,0.0008142592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007268549,"about_ca_system_score_gemma":0.001499432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007167506,"about_ca_topic_score_gemma":0.001559862,"domain_scores_codex":[0.9997589,0.0001093758,0.00002203286,0.00004475378,0.00002373358,0.0000412299],"domain_scores_gemma":[0.9996812,0.00003900251,0.00007785033,0.0000231961,0.00002439738,0.000154352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6320563,0.05024233,0.01095566,0.002345297,0.001282796,0.001345641,0.0004107304,0.004867879,0.1180447,0.001063013,0.01075292,0.1666328],"study_design_scores_gemma":[0.4940159,0.4681307,0.01366816,0.0001163246,0.0004094182,0.00110473,0.00005793156,0.00168459,0.013015,0.0002104945,0.007559343,0.00002733665],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874816,0.003349491,0.0006807289,0.0005736009,0.0001134213,0.002928947,0.001725256,0.0001274266,0.003019478],"genre_scores_gemma":[0.9832731,0.002958722,0.002754196,0.0007727339,0.000150699,0.003499896,0.003527641,0.00003495004,0.003027999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003006794,"threshold_uncertainty_score":0.0100587,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01619898036515756,"score_gpt":0.3026239692669943,"score_spread":0.2864249889018367,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}